ABU DHABI/WAM M42, a global health leader powered by technology, artificial intelligence and genomics, will ...
Read More »It’s hard to win against a CEO with a 300% return
European shareholder activism has suffered a painfully public humiliation. The lesson for investors is clear: Pick your battles. Paris-based investment fund CIAM wanted to split the chairman and CEO roles at French re-insurer Scor SE, which has been run for 17 years by Denis Kessler. In addition, it tried to prevent the reelection of the company’s lead independent director Augustin ...
Read More »